US Patent 10323059 Neuroactive steroids, compositions, and uses thereof
Patent 10323059 was granted and assigned to SAGE Therapeutics on June, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 7, 2017
Date of Patent
June 18, 2019
Patent Applicant
Patent Application Number
15698151
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10323059 Neuroactive steroids, compositions, and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.